Effect of study design on the reported effect of cardiac resynchronization therapy (CRT) on quantitative physiological measures: Stratified meta-analysis in narrow-QRS heart failure and implications for planning future studies

Journal of the American Heart Association

Volumn 4, Issue 1, 2015, Pages

  Jabbour, Richard J ^a   Shun Shin, Matthew J ^a   Finegold, Judith A ^a   Sohaib, S M Afzal ^a   Cook, Christopher ^a   Nijjer, Sukhjinder S ^a   Whinnett, Zachary I ^a   Manisty, Charlotte H ^a   Brugada, Josep ^b   Francis, Darrel P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cardiac resynchronization therapy; Heart failure; Narrow QRS

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; DECISION MAKING; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; META ANALYSIS; NARROW QRS; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; STATISTICAL BIAS; STUDY DESIGN; SYSTEMATIC REVIEW; WALKING; ELECTROCARDIOGRAPHY; EVALUATION STUDY; FEMALE; FORECASTING; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; MALE; MORTALITY; PATIENT CARE PLANNING; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES;

CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; EVALUATION STUDIES AS TOPIC; FEMALE; FORECASTING; HEART FAILURE; HUMANS; MALE; PATIENT CARE PLANNING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR REMODELING;

EID: 85016041158     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000896     Document Type: Article

References (32)

1. Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude DJ, Sherfesee L, Wells GA, Tang AS. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34:3547-3556.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
3. Finegold JA, Raphael C, Levy WC, Whinnett Z, Francis DP. Quantification of survival gain from cardiac resynchronization therapy: non-linear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behaviour. J Am Coll Cardiol. 2013;62:2406-2413.
4. Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J. meta-analysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J. 2008;15:230-236.
5. R Development Core Team. R: a language environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010. [computer program]. Available at: http://www.R-project.org. Accessed January 2014.
6. ggplot2: elegant graphics for data analysis. New York: Springer; 2009. [computer program].
7. Donahue T, Niazi I, Leon A, Stucky M, Herrmann K. Acute and chronic response to CRT in narrow QRS patients. J Cardiovasc Transl Res. 2012;5:232-241.
8. Foley PWX, Patel K, Irwin N, Sanderson JE, Frenneaux MP, Smith REA, Stegemann B, Leyva F. Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study. Heart. 2011;97:1041-1047.
9. Gasparini M, Regoli F, Galimberti P, Ceriotti C, Bonadies M, Mangiavacchi M, Andreuzzi B, Bragato R, Pini D, Klersy C, Gronda E. Three years of cardiac resynchronization therapy: Could superior benefits be obtained in patients with heart failure and narrow QRS? (vol 30, pg S34, 2007). Pacing Clin Electrophysiol. 2007;30:1425.
10. Muto C, Solimene F, Gallo P, Nastasi M, La RC, Calvanese R, Iengo R, Canciello M, Sangiuolo R, Diemberger I, Ciardiello C, Tuccillo B. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Circ Arrhythm Electrophysiol. 2013;6:538-545.
11. Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J III, Gras D, Krum H, Sogaard P, Holzmeister J. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex. N Engl J Med. 2013;369:1395-1405.
12. Thibault B, Harel F, Ducharme A, White M, Ellenbogen KA, Frasure-Smith N, Roy D, Philippon F, Dorian P, Talajic M, Dubuc M, Guerra PG, Macle L, Rivard L, Andrade J, Khairy P. Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex < 120 Milliseconds The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial. Circulation. 2013;127:873-881.
13. van Bommel RJ, Tanaka H, Delgado V, Bertini M, Borleffs CJW, Marsan NA, Holzmeister J, Ruschitzka F, Schalij MJ, Bax JJ, Gorcsan J. Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex. Eur Heart J. 2010;31:3054-3062.
14. van Bommel RJ, Gorcsan J, Chung ES, Abraham WT, Gjestvang FT, Leclercq C, Monaghan MJ, Nihoyannopoulos P, Peraldo C, Yu CM, Demas M, Gerritse B, Bax JJ. Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. Heart. 2010;96:1107-1113.
15. Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, Wu L, Lee AP, Lam YY, Fung JW. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48:2251-2257.
16. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De SS, Guerra R, Patruno N, Serra F. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol. 2003;42:2117-2124.
17. Beshai JF, Grimm RA, Nagueh SF, Baker JH, Beau SL, Greenberg SM, Pires LA, Tchou PJ. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357:2461-2471.
18. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, Bax JJ. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006;48:2243-2250.
19. Tanner-Smith EE, Tipton E. Robust variance estimation with dependent effect sizes: practical considerations including a software tutorial in Stata and SPSS. Res Synth Methods. 2014;5:13-30.
20. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-880.
21. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
22. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, Tockman B, Pochet T, Spinelli J. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 1999;99:2993-3001.
23. Leclercq C, Cazeau S, Ritter P, Alonso C, Gras D, Mabo P, Lazarus A, Daubert JC. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J. 2000;140:862-870.
24. Sohaib SMA, Chen ZC, Whinnett Z, Francis DP, Manisty C. Systematic review of genuine symptomatic response to cardiac resynchronization therapy: acknowledging the contribution of spontaneous response. European Heart Journal 2012; 33:995 (Abstract).
25. Nijjer SS, Pabari PA, Stegemann B, Palmieri V, Leyva F, Linde C, Freemantle N, Davies JE, Hughes AD, Francis DP. The limit of plausibility for predictors of response: application to biventricular pacing. JACC Cardiovasc Imaging. 2012;5:1046-1065.
26. Daniels M, Hill AB. Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials. Br Med J. 1952;1:1162-1168.
27. Ioannidis JPA. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005;294:218-228.
28. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30:459-468.
29. Shun-Shin MJ, Francis DP. Why even more clinical research studies may be false: effect of asymmetrical handling of clinically unexpected values. PLoS One. 2013;8:e65323.
30. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343-1356.
31. Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M, Binder T, Maurer G, Baumgartner H. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291-1295.
32. Rich JD, Cannon CP, Murphy SA, Qin J, Giugliano RP, Braunwald E. Prior aspirin use and outcomes in acute coronary syndromes. J Am Coll Cardiol. 2010;56:1376-1385.